Latest News and Press Releases
Want to stay updated on the latest news?
-
PISCATAWAY, N.J., March 20, 2026 (GLOBE NEWSWIRE) -- BHAV Acquisition Corp (the “Company” or “BHAV”) today announced the closing of its previously announced initial public offering of 10,000,000...
-
Phoenix Energy announces $0.625 preferred share distribution, payable April 15, 2026, to holders of record as of April 1, 2026.
-
CUPERTINO, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that...
-
PISCATAWAY, N.J., March 18, 2026 (GLOBE NEWSWIRE) -- BHAV Acquisition Corp (the “Company” or “BHAV”) today announced the pricing of its initial public offering of 10,000,000 units at an offering...
-
MIAMI, March 17, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type...
-
GEORGE TOWN, CAYMAN ISLANDS, March 13, 2026 (GLOBE NEWSWIRE) -- Metals Acquisition Corp. II (NYSE: MTAL.U) (the “Company”) today announced the closing of its initial public offering of 23,000,000...
-
Las Vegas, Nevada, March 13, 2026 (GLOBE NEWSWIRE) -- SUMA Acquisition Corporation (NASDAQ: SUMAU) (the “Company”) today announced the closing of its initial public offering of 17,250,000 units,...
-
GEORGE TOWN, CAYMAN ISLANDS, March 11, 2026 (GLOBE NEWSWIRE) -- Metals Acquisition Corp. II (the “Company”) today announced the pricing of its initial public offering of 20,000,000 units at a price...
-
VANCOUVER, British Columbia and BOSTON, March 10, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery,...
-
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- GalaxyEdge Acquisition Corporation (NYSE: GLEDU or the “Company”), today announced that the underwriters of its recently announced initial public...